跳至主要内容
临床试验/ISRCTN12184897
ISRCTN12184897终止未知

A multi-centre, randomised controlled, non-inferiority and cost-effectiveness trial comparing polyhexanide and chlorhexidine with neomycin to mupirocin for nasal methicillin-resistant Staphylococcus aureus (MRSA) decolonisation amongst adult hospital in-patients

South Tees Hospitals NHS Foundation Trust0 个研究点目标入组 32 人开始时间: 2022年6月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult in-patient (aged 16 years old or over)
  • 2. Eligible for MRSA screening on admission, based on the local hospital infection control policy, who are found to be colonised with MRSA

排除标准

  • 1. Known hypersensitivity to study treatment(s) or excipients
  • 2. Allergy to peanut and/or soya
  • 3. Day-case admissions
  • 4. Patients identified to be colonised with MRSA in the outpatient setting
  • 5. Previous participation in the TIDE trial or current participation in another trial of a medicinal product that does not allow co-enrolment
  • 6. Patients actively undergoing another decolonisation treatment at the time of recruitment
  • 7. Medical history that might, in the opinion of the attending clinician, put the patient at significant risk if they were to participate in the trial

研究者

相似试验

Trial of MRSA decolonisation treatment in adult... | 临床试验